Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Treatment of urinary incontinence in women

Emily S Lukacz, MD, MAS
Section Editors
Linda Brubaker, MD, FACOG
Kenneth E Schmader, MD
Deputy Editor
Judith A Melin, MA, MD, FACP


Urinary incontinence, the involuntary leakage of urine, is often underdiagnosed and undertreated [1-3]. In one survey, only 60 percent of patients seeking care for leakage (at least once weekly) recalled receiving any treatment for their incontinence [4]. Additionally, nearly 50 percent of those who did receive treatment reported moderate to great frustration with ongoing incontinence.

This topic will discuss the treatment of urinary incontinence in nonpregnant women, focusing on the initial management of stress and stress predominant mixed urinary incontinence.

Overactive bladder (OAB) is a syndrome characterized by urinary urgency, frequency, and nocturia with or without incontinence, and it is treated in a similar manner to urgency incontinence. The treatment of urgency urinary incontinence, OAB and urge predominant mixed urinary incontinence is described separately. (See "Treatment of urgency incontinence/overactive bladder in women".)

The evaluation of urinary incontinence in women and urinary incontinence in men are discussed separately. Urinary incontinence in pregnancy is also discussed separately. (See "Urinary incontinence in men" and "Evaluation of women with urinary incontinence" and "Urinary incontinence and pelvic organ prolapse associated with pregnancy and childbirth".)


Identify indications for referral — Indications for further evaluation or referral for treatment of urinary incontinence include the presence of associated abdominal/pelvic pain, gross or microscopic hematuria in the absence of urinary tract infection, culture-documented recurrent urinary tract infections, new neurologic symptoms, suspected urinary fistula or urethral diverticulum, chronic catheterization, difficulty passing a urinary catheter, pelvic organ prolapse beyond the hymen, history of pelvic reconstructive surgery or pelvic irradiation, or persistently elevated postvoid residual (after treatment of possible causes). (See "Evaluation of women with urinary incontinence", section on 'Specialist referral'.)

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Nov 09, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21:167.
  2. Minassian VA, Yan X, Lichtenfeld MJ, et al. The iceberg of health care utilization in women with urinary incontinence. Int Urogynecol J 2012; 23:1087.
  3. Lukacz ES, Santiago-Lastra Y, Albo ME, Brubaker L. Urinary Incontinence in Women: A Review. JAMA 2017; 318:1592.
  4. Harris SS, Link CL, Tennstedt SL, et al. Care seeking and treatment for urinary incontinence in a diverse population. J Urol 2007; 177:680.
  5. Coyne KS, Thompson CL, Lai JS, Sexton CC. An overactive bladder symptom and health-related quality of life short-form: validation of the OAB-q SF. Neurourol Urodyn 2015; 34:255.
  6. Yalcin I, Bump RC. Validation of two global impression questionnaires for incontinence. Am J Obstet Gynecol 2003; 189:98.
  7. Nygaard I. Clinical practice. Idiopathic urgency urinary incontinence. N Engl J Med 2010; 363:1156.
  8. Dumoulin C, Hay-Smith EJ, Mac Habée-Séguin G. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev 2014; :CD005654.
  9. Rogers RG. Clinical practice. Urinary stress incontinence in women. N Engl J Med 2008; 358:1029.
  10. Abrams P, Andersson KE, Birder L, et al. Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn 2010; 29:213.
  11. Hajiha M, Elterman D. Urinary urgency and frequency in a 53-year-old woman. CMAJ 2016; 188:59.
  12. Olivera CK, Meriwether K, El-Nashar S, et al. Nonantimuscarinic treatment for overactive bladder: a systematic review. Am J Obstet Gynecol 2016; 215:34.
  13. DuBeau CE, Kuchel GA, Johnson T, et al.. Incontinence in the frail elderly. In: Incontinence, 4th ed., Abrams P, Cardozo L, Khoury S, Wein A. (Eds), Health Publications Ltd, Paris 2009. p.961.
  14. Imamura M, Williams K, Wells M, McGrother C. Lifestyle interventions for the treatment of urinary incontinence in adults. Cochrane Database Syst Rev 2015; :CD003505.
  15. Subak LL, Wing R, West DS, et al. Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med 2009; 360:481.
  16. Brown JS, Wing R, Barrett-Connor E, et al. Lifestyle intervention is associated with lower prevalence of urinary incontinence: the Diabetes Prevention Program. Diabetes Care 2006; 29:385.
  17. Wing RR, West DS, Grady D, et al. Effect of weight loss on urinary incontinence in overweight and obese women: results at 12 and 18 months. J Urol 2010; 184:1005.
  18. Phelan S, Kanaya AM, Subak LL, et al. Weight loss prevents urinary incontinence in women with type 2 diabetes: results from the Look AHEAD trial. J Urol 2012; 187:939.
  19. Gleason JL, Richter HE, Redden DT, et al. Caffeine and urinary incontinence in US women. Int Urogynecol J 2013; 24:295.
  20. Dallosso HM, McGrother CW, Matthews RJ, et al. The association of diet and other lifestyle factors with overactive bladder and stress incontinence: a longitudinal study in women. BJU Int 2003; 92:69.
  21. Wood LN, Anger JT. Urinary incontinence in women. BMJ 2014; 349:g4531.
  22. Tähtinen RM, Auvinen A, Cartwright R, et al. Smoking and bladder symptoms in women. Obstet Gynecol 2011; 118:643.
  23. Culbertson S, Davis AM. Nonsurgical Management of Urinary Incontinence in Women. JAMA 2017; 317:79.
  24. Burgio KL. Update on behavioral and physical therapies for incontinence and overactive bladder: the role of pelvic floor muscle training. Curr Urol Rep 2013; 14:457.
  25. Hay-Smith J, Berghmans BK, et al.. Adult conservative management. In: Incontinence, 4th Ed., Abrams P, Cardozo L, Khoury S, Wein A (Eds), Health Publications Ltd, Paris 2009. p.1025.
  26. Shamliyan TA, Kane RL, Wyman J, Wilt TJ. Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann Intern Med 2008; 148:459.
  27. Effective Health Care Program. Nonsurgical Treatments for Urinary Incontinence in Adult Women: Diagnosis and Comparative Effectiveness. Agency for Healthcare Research Quality 2012. Available at: http://effectivehealthcare.ahrq.gov/ehc/products/169/1021/CER36_Urinary-Incontinence_execsumm.pdf (Accessed on November 19, 2012).
  28. Brink CA, Wells TJ, Sampselle CM, et al. A digital test for pelvic muscle strength in women with urinary incontinence. Nurs Res 1994; 43:352.
  29. Hay-Smith EJ, Herderschee R, Dumoulin C, Herbison GP. Comparisons of approaches to pelvic floor muscle training for urinary incontinence in women. Cochrane Database Syst Rev 2011; :CD009508.
  30. Dumoulin C, Hay-Smith J. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev 2010; :CD005654.
  31. Herbison GP, Dean N. Weighted vaginal cones for urinary incontinence. Cochrane Database Syst Rev 2013; :CD002114.
  32. Herderschee R, Hay-Smith EJ, Herbison GP, et al. Feedback or biofeedback to augment pelvic floor muscle training for urinary incontinence in women. Cochrane Database Syst Rev 2011; :CD009252.
  33. Ostaszkiewicz J, Johnston L, Roe B. Timed voiding for the management of urinary incontinence in adults. Cochrane Database Syst Rev 2004; :CD002802.
  34. Ostaszkiewicz J, Johnston L, Roe B. Habit retraining for the management of urinary incontinence in adults. Cochrane Database Syst Rev 2004; :CD002801.
  35. Roe B, Ostaszkiewicz J, Milne J, Wallace S. Systematic reviews of bladder training and voiding programmes in adults: a synopsis of findings from data analysis and outcomes using metastudy techniques. J Adv Nurs 2007; 57:15.
  36. Cody JD, Jacobs ML, Richardson K, et al. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev 2012; 10:CD001405.
  37. Hendrix SL, Cochrane BB, Nygaard IE, et al. Effects of estrogen with and without progestin on urinary incontinence. JAMA 2005; 293:935.
  38. Crandall CJ, Hovey KM, Andrews CA, et al. Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study. Menopause 2017.
  39. Rahn DD, Ward RM, Sanses TV, et al. Vaginal estrogen use in postmenopausal women with pelvic floor disorders: systematic review and practice guidelines. Int Urogynecol J 2015; 26:3.
  40. Richter HE, Burgio KL, Brubaker L, et al. Continence pessary compared with behavioral therapy or combined therapy for stress incontinence: a randomized controlled trial. Obstet Gynecol 2010; 115:609.
  41. Ayeleke RO, Hay-Smith EJ, Omar MI. Pelvic floor muscle training added to another active treatment versus the same active treatment alone for urinary incontinence in women. Cochrane Database Syst Rev 2015; :CD010551.
  42. Lipp A, Shaw C, Glavind K. Mechanical devices for urinary incontinence in women. Cochrane Database Syst Rev 2014; :CD001756.
  43. Malallah MA, Al-Shaiji TF. Pharmacological treatment of pure stress urinary incontinence: a narrative review. Int Urogynecol J 2015; 26:477.
  44. Mariappan P, Ballantyne Z, N'Dow JM, Alhasso AA. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults. Cochrane Database Syst Rev 2005; :CD004742.
  45. Li J, Yang L, Pu C, et al. The role of duloxetine in stress urinary incontinence: a systematic review and meta-analysis. Int Urol Nephrol 2013; 45:679.
  46. Zinner NR, Koke SC, Viktrup L. Pharmacotherapy for stress urinary incontinence : present and future options. Drugs 2004; 64:1503.
  47. Labrie J, Berghmans BL, Fischer K, et al. Surgery versus physiotherapy for stress urinary incontinence. N Engl J Med 2013; 369:1124.
  48. Kang D, Han J, Neuberger MM, et al. Transurethral radiofrequency collagen denaturation for the treatment of women with urinary incontinence. Cochrane Database Syst Rev 2015; :CD010217.
  49. Wyndaele JJ, De Wachter S, Tommaselli GA, et al. A randomized, controlled clinical trial of an intravesical pressure-attenuation balloon system for the treatment of stress urinary incontinence in females. Neurourol Urodyn 2016; 35:252.
  50. Liu Z, Liu Y, Xu H, et al. Effect of Electroacupuncture on Urinary Leakage Among Women With Stress Urinary Incontinence: A Randomized Clinical Trial. JAMA 2017; 317:2493.
  51. Lim R, Liong ML, Leong WS, et al. Pulsed Magnetic Stimulation for Stress Urinary Incontinence: 1-Year Followup Results. J Urol 2017; 197:1302.
  52. Myers DL. Female mixed urinary incontinence: a clinical review. JAMA 2014; 311:2007.
  53. Gomelsky A, Dmochowski RR. Treatment of mixed urinary incontinence in women. Curr Opin Obstet Gynecol 2011; 23:371.
  54. Noblett KL, Cadish LA. Sacral nerve stimulation for the treatment of refractory voiding and bowel dysfunction. Am J Obstet Gynecol 2014; 210:99.
  55. Gross C, Habli M, Lindsell C, South M. Sacral neuromodulation for nonobstructive urinary retention: a meta-analysis. Female Pelvic Med Reconstr Surg 2010; 16:249.
  56. Pfisterer MH, Johnson TM 2nd, Jenetzky E, et al. Geriatric patients' preferences for treatment of urinary incontinence: a study of hospitalized, cognitively competent adults aged 80 and older. J Am Geriatr Soc 2007; 55:2016.
  57. Gormley EA, Lightner DJ, Faraday M, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. J Urol 2015; 193:1572.